Pharmaceutical partner CatSci looks to build on its strategic growth plans following the appointments of two significant industry figures to its senior leadership team. The Cardiff-based firm has appointed Dr Claire Madden-Smith and Andy Jones as board advisors in the hope of shaping its trajectory growth.
Dr Madden-Smith brings over 20 years of experience within the contract sector with previous roles including senior vice president of Juniper Pharma Services where she led the the growth of its contract development and manufacturing offering. She is a non-executive director and strategic consultant to contract service organisations and private equity investors.
Mr Jones has over 30 years' experience in chemistry, manufacturing and controls development and pharma manufacturing services. He has held many senior leadership positions in AstraZeneca, including head of manufacturing, science and technology, and vice president for pharmaceutical innovation. He recently concluded his role as industrial strategy challenge director at Innovate UK.
